Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TRANSITION THERAPEUTICS INC. T.TTH

"Transition Therapeutics Inc is a product-focused biopharmaceutical company. The Company is engaged in developing therapeutics for disease indications with markets. Its technologies are focused on the treatment of Alzheimer's disease and diabetes."


TSX:TTH - Post by User

Post by deninsaskon Nov 27, 2007 12:02am
200 Views
Post# 13871321

HEY POLAK.........

HEY POLAK......... Any idea if Transition is expected to get a Milestone Payment or Progress Payment from Elan upon Initiation of the Phasell for AZD-103 ??? If so how much is it estimated to be. Too lazy to look it up right now.....busy with other things. tia OH ....did I mention that TT-223 Stand Alone has Better Results than either Byetta OR Liraglutide (Novo's STILL UNAPPROVED GLP1 Analogue) did at this stage of the game. Way better when you take into account the Nausea and vomiting that they both induce in Humans.......whereas TT-223 Does Not have ANY Nausea related adverse events in dosing up to 30mg/kg. THATS HUGE!! GLA
Bullboard Posts